Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting (vol 11, pg 2749, 2016)

被引:0
|
作者
Perrone, V
Sangiorgi, D.
Buda, S.
Degli Esposti, L.
机构
关键词
D O I
10.2147/COPD.S130231
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:227 / 227
页数:1
相关论文
共 50 条
  • [21] Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
    Gabriella Gálffy
    Maria Szilasi
    Lilla Tamási
    Pulmonary Therapy, 2019, 5 : 165 - 177
  • [22] Descriptive analysis of multiple myeloma patients in a real-world setting from the Finnish Hematology Registry
    Tskhvarashvili, Giorgi
    Hakkarainen, Katja M.
    Klement, Riho
    Vattulainen, Pia
    Miettinen, Tatu
    Torvinen, Saku
    Lievonen, Juha
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 17 (02):
  • [23] Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study (vol 11, pg 2543, 2016)
    Hashimoto, S.
    Ikeuchi, H.
    Murata, S.
    Kitawaki, T.
    Ikeda, K.
    Banerji, D.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 231 - 231
  • [24] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
    Strange, Charlie
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel R.
    Portillo, Edward
    Feigler, Norbert
    Pollack, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2245 - 2256
  • [25] Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler(R) Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
    Galffy, Gabriella
    Szilasi, Maria
    Tamasi, Lilla
    PULMONARY THERAPY, 2019, 5 (02) : 165 - 177
  • [26] Prevalence of t(11;14) Multiple Myeloma in Real-World Setting: Interim Analysis from the Medici Study
    Spencer, Andrew
    Gavriatopoulou, Maria
    Coriu, Daniel
    Basic, Sandra
    Hajek, Roman
    Pahwa, Ankit
    Taylor, Rebekah
    Lehn, Kristin
    Joehanes, Roby
    Ross, Jeremy A.
    Hader, Carlos
    BLOOD, 2022, 140 : 12481 - 12482
  • [27] Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective
    Zhou, Keruo
    Zhang, Min
    Zuo, Chenyu
    Xie, Xiazhen
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1018 - 1026
  • [28] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
    Strange, C.
    Tkacz, J.
    Schinkel, J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1799 - 1799
  • [29] Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020
    Jin, Jing
    Zhu, Jialei
    Tang, Jing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Trends on treatment patterns in patients with newly diagnosed AML: Preliminary findings from a real-world analysis
    Alessandrini, Ester Rita
    Moreira, Jeverson
    Simon, Virginie
    Mallet, Oscar
    Gamaoun, Rihab
    Pean, Romane
    Hamkoung, Gauvain
    Zuo, Yue
    Reppelin, Theophile
    Kertous, Mehdi
    Templier, Alexandre
    Mounedji, Nadjat
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)